from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1021/-

LFCtreatmentdescriptionclass of inhibitor

-0.697

Amikacinug/mL Amikacintranslation

0.528

Cap5-10ug/mL Capreomycintranslation

-1.010

Rox10-50 ug/mL Roxithromycintranslation

-0.862

SM2-5 ug/mL Streptomycintranslation

-1.146

Tet5-10 ug/mL Tetracyclinetranslation

0.246

Rif0.2-5ug/mL Rifampicintranscription

0.438

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.311

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.361

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.316

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.672

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.249

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.694

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.632

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.223

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.126

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.087

Nigericin50 uM Nigericinrespiration

-0.078

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.226

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.643

menadione6-10 ug/mL Menadionerespiration

-0.193

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.412

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.028

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.430

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.137

NRP_1Non-replicating persistence stage 1dosRassociated

0.247

Amp0.2mg/mL AmpicillincellWall

-0.325

Cephalexin20-100 ug/mL CephalexincellWall

-0.633

Cerulenin0.32-5 ug/mL CerulenincellWall

0.426

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.665

EMB10-20 ug/mL EthambutolcellWall

-1.058

Eta12-40 ug/mL EthionamidecellWall

0.085

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.407

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.110

BZA0.12 mg/mL BenzamidearomaticAmides

0.331

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.205

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.295

H2O24 mM hydrogen peroxideDNAdamaging

-0.038

Levo10 ug/mL LevofloxacinDNAdamaging

0.306

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.737

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.540

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.396

Antimycin12.5-50 ug/mL Antimycin A?

-0.437

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.540

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.772

PA8240.2-2 ug/mL PA-824?

-0.617

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.061

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.295

Verapamil50 uM Verapamil?

-0.595

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.232

methoxatin10-20 ug/mL Methoxatin?